Pancreatic tumors use clotting pathway to build immune shields, study finds
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Pancreatic tumors use clotting pathway to build immune shields, study finds" is generating significant coverage in the Health category, with 4 articles from 4 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Oncodaily, Science Daily, Nature and Medical Xpress. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 1h ago.
Quick answers
Why is "Pancreatic tumors use clotting pathway to build immune shields, study finds" trending?
Because 4 independent news sources published 4 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- Study reveals how pancreatic tumors evade immunotherapy The Peninsula Qatar · 1d ago
- Study Reveals How Pancreatic Tumors Evade Immunotherapy Qatar news agency · 1d ago
- Cosimo Commisso: Pancreatic Cancer Builds Immune Safe Zones to Evade Treatment Oncodaily · 1d ago
- Scientists find a way to break pancreatic cancer’s protective shield Science Daily · 1d ago
- A serpin–myeloid axis in pancreatic cancer heterogeneity and immune evasion Nature · 1d ago
- Pancreatic tumors use clotting pathway to build immune shields, study finds Medical Xpress · 1d ago
Topics
Related trends
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib
Pancreatic cancer specialists are focusing on the new drug daraxonrasib as multiple hospitals join a national initiative.
Pancreatic cancer drug now available in Cleveland offers new hope
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients
A mutant KRAS vaccine yields early positive results in its first human clinical trial for high-risk pancreatic cancer patients.
Pancreatic Cancer Vaccine Triggers Immune Response Before Tumors Develop
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.